These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23667446)

  • 21. Expression of Jagged1/Notch3 Signaling Pathway and their Relationship with the Tumor Angiogenesis in TNBC.
    Xue S; He L; Zhang X; Zhou J; Li F; Wang X
    Arch Med Res; 2017 Feb; 48(2):169-179. PubMed ID: 28625320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between semaphorin 3C and microvessel density in the progression of breast and oral neoplasia.
    Cole-Healy Z; Vergani P; Hunter K; Brown NJ; Reed MW; Staton CA
    Exp Mol Pathol; 2015 Aug; 99(1):19-24. PubMed ID: 25910410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    Goussia A; Simou N; Zagouri F; Manousou K; Lazaridis G; Gogas H; Koutras A; Sotiropoulou M; Pentheroudakis G; Bafaloukos D; Markopoulos C; Patsea H; Christodoulou C; Papakostas P; Zaramboukas T; Samantas E; Kosmidis P; Venizelos V; Karanikiotis C; Papatsibas G; Xepapadakis G; Kalogeras KT; Bamia C; Dimopoulos MA; Malamou-Mitsi V; Fountzilas G; Batistatou A
    PLoS One; 2018; 13(7):e0200302. PubMed ID: 30063723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC9 overexpression confers invasive and angiogenic potential to triple negative breast cancer cells via modulating microRNA-206.
    Salgado E; Bian X; Feng A; Shim H; Liang Z
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1087-1091. PubMed ID: 29936177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.
    Linderholm BK; Hellborg H; Johansson U; Elmberger G; Skoog L; Lehtiö J; Lewensohn R
    Ann Oncol; 2009 Oct; 20(10):1639-46. PubMed ID: 19549711
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
    Guo J; Gong G; Zhang B
    Oncol Rep; 2017 Oct; 38(4):2219-2228. PubMed ID: 28849078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
    Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
    PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NILCO biomarkers in breast cancer from Chinese patients.
    Colbert LS; Wilson K; Kim S; Liu Y; Oprea-Ilies G; Gillespie C; Dickson T; Newman G; Gonzalez-Perez RR
    BMC Cancer; 2014 Apr; 14():249. PubMed ID: 24716804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems.
    Mudvari P; Ohshiro K; Nair V; Horvath A; Kumar R
    PLoS One; 2013; 8(9):e74993. PubMed ID: 24086418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.
    Zhou H; Binmadi NO; Yang YH; Proia P; Basile JR
    Angiogenesis; 2012 Sep; 15(3):391-407. PubMed ID: 22476930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
    Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
    Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropilins in the Context of Tumor Vasculature.
    Niland S; Eble JA
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.
    Kim EK; Park AK; Ko E; Park WY; Lee KM; Noh DY; Han W
    Breast Cancer Res Treat; 2019 Nov; 178(1):185-197. PubMed ID: 31342312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple-negative breast cancer: investigating potential molecular therapeutic target.
    Papa A; Caruso D; Tomao S; Rossi L; Zaccarelli E; Tomao F
    Expert Opin Ther Targets; 2015 Jan; 19(1):55-75. PubMed ID: 25307277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The semaphorins and their receptors as modulators of tumor progression.
    Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
    Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
    Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
    Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
    Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
    Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.